微创脑科学(02172.HK)于2024年12月17日盘中大涨5.48%,引起市场广泛关注。此前,该公司于2024年12月16日(交易时段后)公布,其全资附属公司微创神通医疗科技(上海)与深圳市引导基金、光明区引导基金等多家机构签订合伙协议,成立"深圳市中金脑科学与类脑智能产业私募股权投资基金"。
根据协议,该投资基金总资本承诺为人民币10亿元,其中微创神通出资2亿元,占基金20%权益。微创神通是基金的有限合伙人,不会将该投资基金纳入合并报表范围。投资基金将致力于脑科学及类脑智能行业的股权投资、资产管理和其他投资管理服务。
公司董事会认为成立该投资基金有利于支持微创脑科学的多元化发展战略,提升其在脑科学前沿领域的竞争力,有望带来新的业务机会和增长前景。市场对此消息反映积极,助推微创脑科学当日股价大涨。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.